Ausgabe 2/2020
Inhalt (12 Artikel)
Measuring horizontal inequity in healthcare utilisation: a review of methodological developments and debates
Mohammad Habibullah Pulok, Kees van Gool, Mohammad Hajizadeh, Sara Allin, Jane Hall
The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah, Sameen Abbas
Corruption and health outcomes within an economic and cultural framework
Monica Violeta Achim, Viorela Ligia Văidean, Sorin Nicolae Borlea
Why are there long waits at English emergency departments?
James Gaughan, Panagiotis Kasteridis, Anne Mason, Andrew Street
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
M. Campioni, I. Agirrezabal, R. Hajek, J. Minarik, L. Pour, I. Spicka, S. Gonzalez-McQuire, P. Jandova, V. Maisnar
The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France
Gérard de Pouvourville, Patrick Blin, Pierre Karam
The company you keep: health behavior among work peers
Gerald J. Pruckner, Thomas Schober, Katrin Zocher
The impact of prescription drug co-payments for publicly insured families
Gretta Mohan, Anne Nolan
How averse are the UK general public to inequalities in health between socioeconomic groups? A systematic review
Simon McNamara, John Holmes, Abigail K. Stevely, Aki Tsuchiya
Economic evaluation of meningococcal vaccines: considerations for the future
Hannah Christensen, Hareth Al-Janabi, Pierre Levy, Maarten J. Postma, David E. Bloom, Paolo Landa, Oliver Damm, David M. Salisbury, Javier Diez-Domingo, Adrian K. Towse, Paula K. Lorgelly, Koonal K. Shah, Karla Hernandez-Villafuerte, Vinny Smith, Linda Glennie, Claire Wright, Laura York, Raymond Farkouh